LONDON – "This is not about doing the easy thing, but the right thing," said David Brennan, CEO of AstraZeneca plc, at the launch of a new code of practice for pharmaceutical companies, which for the first time has been extended beyond marketing practices, to set out the terms of engagement for all pharma industry interactions with health care professionals, hospitals and patients' organizations.